Ask AI

Addressing Challenges and Implementing Care Strategies to Optimize BCMA Bispecific Antibody Therapy in RRMM: Expert Insights, Patient Resources, and Adaptive Decision Support

Enhance your understanding of BCMA bispecific antibodies currently used to manage relapsed/refractory multiple myeloma to optimize therapy and improve adherence through an interactive decision support tool, certified interactive case challenge and on-demand webcast, expert-written ClinicalThought commentary, podcast, downloadable resources, and downloadable slides.

Share

Program Content

Activities

MM BsAb Patient Resource
What I Wish I’d Known Before Starting Bispecific Antibody Therapy for Multiple Myeloma: A Patient Resource
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: November 20, 2025

BsAb AE Resource
Bispecific Antibodies for Relapsed/Refractory Multiple Myeloma: Efficacy and Safety Considerations 
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: January 30, 2026

Activities

BsAb Challenge
Individualizing Therapy for Relapsed/Refractory Multiple Myeloma: Bispecific Antibody Therapy
Case Challenge
Congratulations: You achieved a completion on 04/09/2022

Released: December 31, 2025

Expires: June 30, 2026

Activities

BsAb Therapy in RRMM
Addressing Challenges and Implementing Care Strategies to Optimize BCMA Bispecific Antibody Therapy in RRMM: Expert Insights, Patient Resources, and Adaptive Decision Support
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: January 22, 2026

Activities

BCMA BsAbs in RRMM
Addressing Challenges and Implementing Care Strategies to Optimize BCMA Bispecific Antibody Therapy in RRMM: Expert Insights, Patient Resources, and Adaptive Decision Support
Video
Congratulations: You achieved a completion on 04/09/2022

Released: February 16, 2026

Expires: August 15, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education in partnership with Smart Patients.

Supporters

Supported by an educational grant from Pfizer Inc.

Pfizer Inc.

Partners

Smart Patients

ProCE Banner